首页> 外文会议>European Symposium on Organic Chemistry >Highly Stereoselective Biocatalytic Reductions for the Synthesis of Chiral Intermediates(Abstracts)
【24h】

Highly Stereoselective Biocatalytic Reductions for the Synthesis of Chiral Intermediates(Abstracts)

机译:对手性中间体合成的高度立体化生物催化减少(摘要)

获取原文

摘要

The asymmetric reduction of ketones is one of the most important, fundamental and practical reactions for producing non-racemic chiral alcohols, which can be transformed into various functionalities, without racemization, to synthesize industrially important chemicals such as pharmaceuticals, agrochemicals and natural products. Biocatalytic reduction of α-alkyl-1,3-diketones 1, and α-alkyl-β-keto esters employing isolated NADPH-dependent ketoreductases (KREDs) proved to be a highly efficient method for the preparation of optically pure keto-alcohols 2, 1,3-diols 3 or hydroxy esters.[3,4] These chiral compounds are very important in asymmetric organic synthesis, where they are used as building blocks for synthesis of polyketides, statins, protease inhibitors, and other important pharmaceuticals. The ability to synthesize various single diastereomers of the same compound, is desirable when libraries of pharmaceutical compounds are synthesized and tested for biological activity.
机译:酮的不对称还原是生产非外消旋手性腺醇的最重要,基本和实用的反应之一,可以转化为各种功能,无需定向,以综合工业上重要的化学品,例如药物,农用化学品和天然产物。将α-烷基-1,3-二酮1和使用分离的NADPH依赖性酮还原酶(KREDS)的生物催化还原α-烷基-β-酮酯(KEDS)被证明是制备光学纯酮醇2的高效方法, 1,3-二醇3或羟基酯。[3,4]这些手性化合物在不对称的有机合成中非常重要,其中它们用作合成聚酮化合物,汀类药物,蛋白酶抑制剂和其他重要药物的构建块。当合成药物化合物的文库并测试生物活性时,期望合成相同化合物的各种单一非对映异构体的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号